According to a new study published by the journal BioMed Research International, tetrahydrocannabinol (THC) may be “a potential new target for the treatment of diabetes-induced cardiovascular disease.” “The aim of this study was to determine if chronic, low-dose administration of a nonspecific cannabinoid receptor agonist could provide cardioprotective effects in a model of type I diabetes mellitus”, states …
Activation of the cannabinoid 2 receptor – done naturally through the consumption of cannabis and cannabinoids – may be a potential treatment option for insulin resistance and obesity-related diabetes. This is according to new research out of the Institute of Biomedical Engineering at the Chinese Academy of Medical Science; the study was study published in …
The journal European Neuropsychopharmacology has published a study showing that cannabinoids may provide a treatment option for depression associated with diabetes. “The pathophysiology associated with increased prevalence of depression in diabetics is not completely understood, although studies have pointed the endocannabinoid system as a possible target”, researchers state. With this in mind, they “aimed to …
By Paul Armentano, NORML A history of cannabis use is associated with a lower likelihood of obesity and diabetes, according to population-based data published in the journal Obesity. Investigators from the Conference of Quebec University Health Centers assessed cannabis use patterns and body mass index (BMI) in a cohort of 786 Inuit (Arctic aboriginal) adults …
By Laird Harrison, Medscape Inhaled cannabis can blunt the pain of diabetic neuropathy without seriously impairing cognitive function, a new study shows. “The higher the dose, the more the pain relief,” first author Mark Wallace, MD, told Medscape Medical News. “There was, however, a dose-dependent increase in euphoria.” The study is the first randomized controlled …
Individuals with a history of cannabis use are less likely to have diabetes, according to a new study being published in the journal Epidemiology, and published online ahead of print by the U.S. National Institute of Health. “Recently active cannabis smoking and diabetes mellitus are inversely associated,” claim reservoirs after performing a meta-study assessing cannabis …
A new study just released out of the U.K., and recently published in the Journal of Neurology, has examined the efficacy of the THC/CBD oromucosal spray Sativex on peripheral neuropathic pain (PNP). The peripheral nervous system connects nerves from the spinal cord and brain to the rest of the body; the pain associated with peripheral …
A study published this month by the journal Cell Biochemistry and Function, and published online by the U.S. National Institute of Health, has found promising evidence to suggest that delta-9-tetrahydrocannabinol (THC) may provide a safe and effective treatment option for those with diabetes. For the study; “Rats were randomly divided into four groups: control, Δ9 …
